Vectormune ND

Pays: Union européenne

Langue: croate

Source: EMA (European Medicines Agency)

Ingrédients actifs:

živi rekombinantni turkey herpes virus (rHVT / ND) povezan s stanicom, koji eksprimira fuzijski protein Newcastle bolesti virusa D-26 lentogenog soja

Disponible depuis:

CEVA-Phylaxia Co. Ltd.

Code ATC:

QI01AD

DCI (Dénomination commune internationale):

Newcastle disease and Marek’s disease vaccine (live recombinant)

Groupe thérapeutique:

Chicken; Embryonated eggs

Domaine thérapeutique:

Imunomodulatori za Aves živih virusnih cjepiva

indications thérapeutiques:

Za aktivne imunizacije 18 dana-starog эмбрионами kokošjih jaja ili dnevne pilića za smanjenje smrtnosti i kliničkih znakova, uzrokovane virusa Ньюкаслской bolesti i smanjiti smrtnost, klinički simptomi i lezije uzrokovane Марека bolesti zaraze s фенотипом "вирулентный".

Descriptif du produit:

Revision: 7

Statut de autorisation:

odobren

Date de l'autorisation:

2015-09-08

Notice patient

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Ažurirane informacije o ovom veterinarsko-medicinskom proizvodu
dostupne su na mrežnom mjestu s
informacijama o veterinarsko-medicinskim proizvodima.

Résumé des caractéristiques du produit

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Ažurirane informacije o ovom veterinarsko-medicinskom proizvodu
dostupne su na mrežnom mjestu s
informacijama o veterinarsko-medicinskim proizvodima.